Story perspectives
Doctor Warns of 'Ozempic Vagina' Risks for Women
9/13/2025
32 2
1 of 1
Story summary
- Dr. Natasha Bhuyan addresses "Ozempic vagina," which describes vulvar changes following weight loss from GLP-1 medications.
- Rapid fat loss may cause vaginal dryness and pelvic floor weakness due to estrogen deficiency.
- GLP-1 drugs, including Ozempic, are not advised during pregnancy or breastfeeding.
- Concerns exist regarding GLP-1s potentially impacting oral contraceptive effectiveness.
- Women should seek guidance from healthcare providers for tailored treatment and symptom management.
